clinmedКлиническая медицинаClinical Medicine (Russian Journal)0023-21492412-1339ООО «Медицинское информационное агентство»10.30629/0023-2149-2021-99-11-12-593-601clinmed-314Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESПрофилактика тромбоэмболических осложнений в гинекологической практикеPrevention of thromboembolic events in gynaecological practicehttps://orcid.org/0000-0002-7426-9040МельниковА. П.MelnikovA. P.

Мельников Андрей Павлович — канд. мед. наук, акушер-гинеколог

101000, Москва

Melnikov Andrey P.

101000, Moscow

https://orcid.org/0000-0003-2679-3734ЩербатыхМ. Г.ShcherbatykhM. G.

Щербатых Марина Геннадьевна — аспирант 

101000, Москва

Shcherbatykh Marina G.

101000, Moscow

marina.kaschchuk@yandex.ruГБУЗ МО «Московский областной научно-исследовательский институт акушерства и гинекологии»РоссияMoscow Regional Research Institute of Obstetrics and GynecologyRussian Federation2021040320229911-12593601Copyright © Мельников А.П., Щербатых М.Г., 20222022Мельников А.П., Щербатых М.Г.Melnikov A.P., Shcherbatykh M.G.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.clinmedjournal.com/jour/article/view/314

В обзоре представлены современные данные по профилактике тромбоэмболических осложнений в оперативной гинекологии. Особое внимание уделено определению клинической вероятности тромботических осложнений, стратификации пациенток по группам риска с учетом хирургической и экстрагенитальной патологии, особенностям оперативного вмешательства, использованию лабораторных и инструментальных методик, а также продолжительности и объему фармакологической тромбопрофилактики после оперативного вмешательства.

The review presents current data on the prevention of thromboembolic events in operative gynecology. Specifi c attention is paid to the determination of the clinical expectancy of thrombotic events, the stratifi cation of patients by risk groups, taking into account surgical and extragenital pathology, the peculiar features of surgical intervention, the use of laboratory and instrumental techniques, as well as the duration and the extent of pharmacological prevention of thromboembolic events after surgery.

тромбозыоперативная гинекологияпрофилактиканизкомолекулярные гепаринытромбодинамикатромбоэластографияthrombosisoperative gynecologypreventionlow molecular weight heparinthrombodynamicsthromboelastographyReferencesБокарев И.Н. Венозный тромбоэмболизм и тромбоэмболия легочной артерии. М.: МИА, 2005:205.Bokarev I.N. Venous thromboembolism and pulmonary embolism. Moscow: MIA, 2005:205. (in Russian)Рекомендации ESC по диагностике и ведению пациентов с острой эмболией системы легочной артерии. Российский кардиологический журнал. 2015;8:67–110.ESC recommendations for the diagnosis and management of patients with acute pulmonary embolism. Russian Journal of Cardiology. 2015;8:67–110. (in Russian)Духин А.О. Профилактика венозных тромбоэмболических осложнений при хирургическом лечении пациенток с гинекологическими заболеваниями. Лечащий Врач. 2014;3:48–51.Dukhin A.O. Prevention of venous thromboembolic complications in the surgical treatment of patients with gynecological diseases. Attending Physician. 2014;3:48–51. (in Russian)Озолиня Л.А. Венозные тромбоэмболические осложнения в акушерстве и гинекологии. Монография. ГЕОТАР-Медиа. 2015:256.Ozolinya L.A. Venous thromboembolic complications in obstetrics and gynecology. Monograph. GEOTAR-Media. 2015:256. (in Russian)Тихомиров А.Л. Профилактика тромбоэмболических осложнений в послеоперационном периоде в гинекологии. Гинекология. 2006;8(1):41–43.Tikhomirov A.L. Prevention of thromboembolic complications in the postoperative period in gynecology. Gynecology. 2006;8(1):41–43. (in Russian)White R.H. The Epidemiology of Venous Thromboembolism. Circulation. 2003;107(23):14–18.White R.H. The Epidemiology of Venous Thromboembolism. Circulation. 2003;107(23):14–18.Глушков Н.И. Наш опыт профилактики послеоперационных венозных тромбоэмболических осложнений у пациентов пожилого и старческого возраста. Вестник СПб. Медицинской академии последипломного образования. 2011;3:38–42.Glushkov N.I. Our experience in the prevention of postoperative venous thromboembolic complications in elderly and senile patients. Bulletin of St. Petersburg. Medical Academy of Postgraduate Education. 2011;3:38–42. (in Russian)Goldhaber S.Z., Bounameaux H. Pulmonary embolism and deep vein thrombosis. Lancet. 2012;379:1835–1846.Goldhaber S.Z., Bounameaux H. Pulmonary embolism and deep vein thrombosis. Lancet. 2012;379:1835–1846.Murin S., Romano P.S., White RH. Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embo lism. Thromb. Haemost. 2002;88:407–414.Murin S., Romano P.S., White RH. Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embo lism. Thromb. Haemost. 2002;88:407–414.Watson H. et.al. Guideline on aspects of cancer-related venous thrombosis. Br. J. Haematol. 2015;170(5):640–8.Watson H. et.al. Guideline on aspects of cancer-related venous thrombosis. Br. J. Haematol. 2015;170(5):640–8.Карташева А. Тромбоэмболия легочной артерии. Новые рекомендации ESC (2008). Medicine Review. 2008;4:56–64.Kartasheva A. Pulmonary embolism. New ESC Recommendations (2008). Medicine Review. 2008;4:56–64. (in Russian)Keeling D., Tait R.C., Watson H. Peri-operative management of anticoagulation and antiplatelet Therapy. British Committee for Standards in Haematology. British Journal of Haematology. 2016;175:602–613.Keeling D., Tait R.C., Watson H. Peri-operative management of anticoagulation and antiplatelet Therapy. British Committee for Standards in Haematology. British Journal of Haematology. 2016;175:602–613.Кулаков В.Н. Интенсивная терапия в акушерстве и гинекологии. М.: Медицинское информационное агентство. 1998:.206.Kulakov V.N. Intensive care in obstetrics and gynecology. Moscow: Medical Information Agency. 1998:206. (in Russian)Kesteren P., Hanley J., Lotigbney A.D. Pregnancy-associated venous thrombosis. Phlebology. 2012;27:73–80.Kesteren P., Hanley J., Lotigbney A.D. Pregnancy-associated venous thrombosis. Phlebology. 2012;27:73–80.Qu H., Li Z., Zhai Z., Liu C., Wang S., Guo S., Zhang Z. Predicting of Venous Thromboembolism for Patients Undergoing Gynecological Surgery. Medicine (Baltimore). 2015;94(39):1653.Qu H., Li Z., Zhai Z., Liu C., Wang S., Guo S., Zhang Z. Predicting of Venous Thromboembolism for Patients Undergoing Gynecological Surgery. Medicine (Baltimore). 2015;94(39):1653.Mahan C.E. Venous thromboembolism pharmacy intervention management program with an active, multifaceted approach reduces preventable venous thromboembolism and increases appropriate prophylaxis. Clin. Appl. Thromb. Hemost. 2012;18:45–58.Mahan C.E. Venous thromboembolism pharmacy intervention management program with an active, multifaceted approach reduces preventable venous thromboembolism and increases appropriate prophylaxis. Clin. Appl. Thromb. Hemost. 2012;18:45–58.Amin T., Cohen H., Wong M., Goodhart V., Pointer S.L., Jurkovic D. The prevalence of incidental uterine venous plexus thrombosis in women attending a gynecology clinic. J. Thromb. Haemost. 2020;18(10):2557–2565.Amin T., Cohen H., Wong M., Goodhart V., Pointer S.L., Jurkovic D. The prevalence of incidental uterine venous plexus thrombosis in women attending a gynecology clinic. J. Thromb. Haemost. 2020;18(10):2557–2565.Буянова С.Н. Особенности профилактики тромбоэмболическихи гнойносептических осложнений в оперативной гинекологии. Российский вестник акушера-гинеколога. 2016;16(6):38–46.Buyanova S.N. Features of prevention of thromboembolic and purulent septic complications in surgical gynecology. Russian Bulletin of Obstetrician-Gynecologist. 2016;16(6):38–46. (in Russian)Pretorius L., Thomson G.J.A., Adams R.C.M., Nell T.A., Laubscher W.A, Pretorius E. Platelet activity and hypercoagulation in type 2 diabetes. Cardiovasc. Diabetol. 2018;17(1):141.Pretorius L., Thomson G.J.A., Adams R.C.M., Nell T.A., Laubscher W.A, Pretorius E. Platelet activity and hypercoagulation in type 2 diabetes. Cardiovasc. Diabetol. 2018;17(1):141.Cavender M.A., Steg P.G., Smith S.C. Jr., Eagle K., Ohman E.M., Goto S., Kuder J., Im K., Wilson P.W., Bhatt D.L. REACH Registry Investigators. Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Circulation. 2015;132(10):923–31.Cavender M.A., Steg P.G., Smith S.C. Jr., Eagle K., Ohman E.M., Goto S., Kuder J., Im K., Wilson P.W., Bhatt D.L. REACH Registry Investigators. Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Circulation. 2015;132(10):923–31.Кириенко А.И., Леонтьев С.Г., Лебедев И.С., Селиверстов Е.И. Профилактика венозных тромбоэмболических осложнений в хирургической практике. Consilium Medicum. 2006;8(7):78–80.Kirienko A.I., Leontiev S.G., Lebedev I.S., Seliverstov E.I. Prevention of venous thromboembolic complications in surgical practice. Consilium Medicum. 2006;8(7):78–80. (in Russian)Fernandes C.J., Morinaga L.T.K., Alves J.L. Jr., Castro M.A., Calderaro D., Jardim C.V.P., Souza R. Cancer-associated thrombosis: the when, how and why. Eur. Respir. Rev. 2019;28(151):180119.Fernandes C.J., Morinaga L.T.K., Alves J.L. Jr., Castro M.A., Calderaro D., Jardim C.V.P., Souza R. Cancer-associated thrombosis: the when, how and why. Eur. Respir. Rev. 2019;28(151):180119.Suzuki N., Yoshioka N., Ohara T., Yokomichi N., Nako T., Yahagi N., Igarashi S., Kobayashi Y., Yoshimatsu M., Takizawa K., Naka jima Y., Kiguchi K., Ishizuka B. Risk factors for perioperative venous thromboembolism: A retrospective study in Japanese women with gynecologic diseases. Thromb. J. 2010;8:17.Suzuki N., Yoshioka N., Ohara T., Yokomichi N., Nako T., Yahagi N., Igarashi S., Kobayashi Y., Yoshimatsu M., Takizawa K., Naka jima Y., Kiguchi K., Ishizuka B. Risk factors for perioperative venous thromboembolism: A retrospective study in Japanese women with gynecologic diseases. Thromb. J. 2010;8:17.Shiota M., Kotani Y., Umemoto M., Tobiume T., Tsuritani M., Shimaoka M., Hoshiai H. Deep-vein thrombosis is associated with large uterine fi broids. Tohoku J. Exp. Med. 2011;(2):87–9.Shiota M., Kotani Y., Umemoto M., Tobiume T., Tsuritani M., Shimaoka M., Hoshiai H. Deep-vein thrombosis is associated with large uterine fi broids. Tohoku J. Exp. Med. 2011;(2):87–9.Geerts W.H., Heit J.A., Clagett G.P., Pineo G.F., Colwell C.W., Anderson F.A., Wheeler H.B. Prevention of venous thromboembolism. Chest. 2001;119(1):132–175.Geerts W.H., Heit J.A., Clagett G.P., Pineo G.F., Colwell C.W., Anderson F.A., Wheeler H.B. Prevention of venous thromboembolism. Chest. 2001;119(1):132–175.Spotnitz W.D. Active and mechanical hemostatic agents. Surgery. 2007;142:34–8.Spotnitz W.D. Active and mechanical hemostatic agents. Surgery. 2007;142:34–8.Wright J.D., Ananth C.V., Lewin S.N., Burke W.M., Siddiq Z., Neugut A.I., Herzog T.J., Hershman D.L. Patterns of use of hemostatic agents in patients undergoing major surgery. J. Surg. Res. 2014;186(1):458–66.Wright J.D., Ananth C.V., Lewin S.N., Burke W.M., Siddiq Z., Neugut A.I., Herzog T.J., Hershman D.L. Patterns of use of hemostatic agents in patients undergoing major surgery. J. Surg. Res. 2014;186(1):458–66.Буянова С.Н. с соавт. Определение факторов высокого риска тромбоэмболических осложнений в послеоперационном периоде у женщин с гинекологическими заболеваниями, нарушающими функцию смежных органов. Алгоритм диагностики и профилактики. Информационно-методическое письмо. 2019.Buyanova S.N. et al. Determination of high risk factors for thromboembolic complications in the postoperative period in women with gynecological diseases that impair the function of adjacent organs. Algorithm for diagnostics and prevention. Information and methodological letter. 2019. (in Russian)Wells P.S. Integrated strategies for the diagnosis of venous thromboembolism. J. Thrombosis Haemostasis. 2007;5(s1):41–50.Wells P.S. Integrated strategies for the diagnosis of venous thromboembolism. J. Thrombosis Haemostasis. 2007;5(s1):41–50.Pomero F., Dentali F., Borretta V, Bonzini M., Melchio R., Douketis J.D., Fenoglio L.M. Accuracy of emergency physicianperformed ultrasonography in the diagnosis of deep-vein thrombosis: a systematic review and meta-analysis. Thromb. Haemost. 2013;109(1):137–45.Pomero F., Dentali F., Borretta V, Bonzini M., Melchio R., Douketis J.D., Fenoglio L.M. Accuracy of emergency physicianperformed ultrasonography in the diagnosis of deep-vein thrombosis: a systematic review and meta-analysis. Thromb. Haemost. 2013;109(1):137–45.Под редакцией Ю.Л. Шевченко, Ю.М. Стойко. Основы клинический флебологии, 2-е издание. Учебник. 2013.Edited by Yu.L. Shevchenko, Yu.M. Stoyko. Fundamentals of clinical phlebology, 2nd edition. Textbook, 2013. (in Russian)Яковлев В.Б. Тромбоэмболия легочной артерии. Кардиология. 2005Yakovlev V.B. Pulmonary embolism. Cardiology. 2005. (in Russian)Guidelines on the diagnosis and management of acute pulmonary embolism. The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). European Heart Journal. 2008;29:2276–2315.Guidelines on the diagnosis and management of acute pulmonary embolism. The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). European Heart Journal. 2008;29:2276–2315.Shi J., Ye J., Zhuang X., Cheng X., Fu R., Zhao A. Application value of Caprini risk assessment model and elevated tumor-specifi c D-dimer level in predicting postoperative venous thromboembolism for patients undergoing surgery of gynecologic malignancies. J. Obstet. Gynaecol. Res. 2019;45(3):657–664.Shi J., Ye J., Zhuang X., Cheng X., Fu R., Zhao A. Application value of Caprini risk assessment model and elevated tumor-specifi c D-dimer level in predicting postoperative venous thromboembolism for patients undergoing surgery of gynecologic malignancies. J. Obstet. Gynaecol. Res. 2019;45(3):657–664.Kjellberg U., Hellgren M. Sonoclot signature during normal pregnancy. Intensive Care Med. 2000;26(2):206–11.Kjellberg U., Hellgren M. Sonoclot signature during normal pregnancy. Intensive Care Med. 2000;26(2):206–11.Hemker H.C., Al Dieri R., Beguin S. Curr. Opin. Hematol. 2004;11:170–175.Hemker H.C., Al Dieri R., Beguin S. Curr. Opin. Hematol. 2004;11:170–175.Серебрийский И.И. «Глобальные» и «локальные» тесты системы гемостаза в диагностике гиперкоагуляционного синдрома. Справочник заведующего клинико-диагностической лабораторией. 2012;12.Serebriyskiy I.I. «Global» and «local» tests of the hemostasis system in the diagnosis of hypercoagulable syndrome. Reference book of the head of the clinical diagnostic laboratory. 2012;12. (in Russian)Hartert H. et al. Blutgerinnungsstudien mit der Thrombelastographie, einem neuen Untersuchungs verfahren. J. Klin. Wochenschrift. 1948;26:577–583.Hartert H. et al. Blutgerinnungsstudien mit der Thrombelastographie, einem neuen Untersuchungs verfahren. J. Klin. Wochenschrift. 1948;26:577–583.Gould M.K., Garcia D.A., Wren S.M., Karanicolas P.J., Arcelus J.I., Heit J.A., Samama C.M. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2):e227S–e277S.Gould M.K., Garcia D.A., Wren S.M., Karanicolas P.J., Arcelus J.I., Heit J.A., Samama C.M. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2):e227S–e277S.Sang C.Q., Zhao N., Zhang J., Wang S.Z., Guo S.L., Li S.H., Jiang Y., Li B., Wang J.L., Song L., Zhai J.J., Zhang Z.Y. Diff erent combination strategies for prophylaxis of venous thromboembolism in patients: A prospective multicenter randomized controlled study. Sci. Rep. 2018;8(1):8277.Sang C.Q., Zhao N., Zhang J., Wang S.Z., Guo S.L., Li S.H., Jiang Y., Li B., Wang J.L., Song L., Zhai J.J., Zhang Z.Y. Diff erent combination strategies for prophylaxis of venous thromboembolism in patients: A prospective multicenter randomized controlled study. Sci. Rep. 2018;8(1):8277.Feng J.P., Xiong Y.T., Fan Z.Q., Yan L.J., Wang J.Y., Gu Z.J. Effi cacy of intermittent pneumatic compression for venous thromboembolism prophylaxis in patients undergoing gynecologic surgery: A systematic review and meta-analysis. Oncotarget. 2017;8(12):20371–20379.Feng J.P., Xiong Y.T., Fan Z.Q., Yan L.J., Wang J.Y., Gu Z.J. Effi cacy of intermittent pneumatic compression for venous thromboembolism prophylaxis in patients undergoing gynecologic surgery: A systematic review and meta-analysis. Oncotarget. 2017;8(12):20371–20379.Емельянов Д.Н., Сергеев В.С. Антикоагулянты в кардиологической практике. Лекарственный вестник. 2013;7(3):20–26.Emelyanov D.N., Sergeev V.S. Anticoagulants in cardiological practice. Medicinal Herald. 2013;7(3):20–26. (in Russian)Гиляров М.Ю. Ривароксабан в профилактике тромбоэмболических осложнений у пациентов с фибрилляцией предсердий. Рациональная фармакотерапия в кардиологии. 2012;8(3):453– 456.Gilyarov M.Yu. Rivaroxaban in the prevention of thromboembolic complications in patients with atrial fi brillation. Rational pharmacotherapy in cardiology. 2012;8(3):453–456. (in Russian)Lip G.Y., Nieuwlaat R., Pisters R. et al. Refi ning clinical risk stratifi cation for predicting stroke and thromboembolism in atrial fi brillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fi brillation. Chest. 2010;137:263–272.Lip G.Y., Nieuwlaat R., Pisters R. et al. Refi ning clinical risk stratifi cation for predicting stroke and thromboembolism in atrial fi brillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fi brillation. Chest. 2010;137:263–272.Franchi L., Patrelli T.S., Berretta R., Rolla M., Gizzo S., Gramellini D., Bacchi Modena A., Nardelli G.B. Role of D-dimer testing in severe pelvic infl ammatory disease: a new usable marker to assess the need for fertility-impairing surgery? Fertil. Steril. 2010;94(6):2372–5.Franchi L., Patrelli T.S., Berretta R., Rolla M., Gizzo S., Gramellini D., Bacchi Modena A., Nardelli G.B. Role of D-dimer testing in severe pelvic infl ammatory disease: a new usable marker to assess the need for fertility-impairing surgery? Fertil. Steril. 2010;94(6):2372–5.Liu J., Wang N., Chen Y., Lu R., Ye X. Thrombelastography coagulation index may be a predictor of venous thromboembolism in gynecological oncology patients. J. Obstet. Gynaecol. Res. 2017;43(1):202–210.Liu J., Wang N., Chen Y., Lu R., Ye X. Thrombelastography coagulation index may be a predictor of venous thromboembolism in gynecological oncology patients. J. Obstet. Gynaecol. Res. 2017;43(1):202–210.Nates J.L., Aravindan N., Hirsch-Ginsberg C., Sizer K.C., Kee S, Nguyen A.T., Chen K., Shaw A.D., Price K.J. Critically ill cancer patients are not consistently hypercoagulable after craniotomy. Neurocrit. Care. 2007;7(3):211–6.Nates J.L., Aravindan N., Hirsch-Ginsberg C., Sizer K.C., Kee S, Nguyen A.T., Chen K., Shaw A.D., Price K.J. Critically ill cancer patients are not consistently hypercoagulable after craniotomy. Neurocrit. Care. 2007;7(3):211–6.

The authors declare that there are no conflicts of interest present.